Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] (2019)
- Authors:
- Sousa, Juliana Cordeiro
- Ito, Mayumi Nóbrega
- Costa, Marilia Braga
- Farias, Izabelle Rocha
- Borges, Daniela Paula
- Oliveira, Roberta Taiane
- Fukutani, Kiyoshi Ferreira
- Thomé, Carolina Hassibe
- Martinelli, Camila Maria Silva
- Myajima, Fabio
- Vidal, Daniel Onofre
- Magalhães, Silvia Maria Meira
- Pontes, Lorena Lobo de Figueiredo
- Pinheiro, Ronald Feitosa
- USP affiliated authors: PONTES, LORENA LÔBO DE FIGUEIREDO - FMRP ; FUKUTANI, KIYOSHI FERREIRA - FMRP
- Unidade: FMRP
- DOI: 10.1002/hon.2608
- Subjects: HEMATOLOGIA; CÉLULAS DA MEDULA ÓSSEA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Hematological Oncology
- ISSN: 0278-0232
- Volume/Número/Paginação/Ano: v. 37, n. 4, p. 523-526, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SOUSA, Juliana Cordeiro et al. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta]. Hematological Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/hon.2608. Acesso em: 21 maio 2024. , 2019 -
APA
Sousa, J. C., Ito, M. N., Costa, M. B., Farias, I. R., Borges, D. P., Oliveira, R. T., et al. (2019). Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta]. Hematological Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/hon.2608 -
NLM
Sousa JC, Ito MN, Costa MB, Farias IR, Borges DP, Oliveira RT, Fukutani KF, Thomé CH, Martinelli CMS, Myajima F, Vidal DO, Magalhães SMM, Pontes LL de F, Pinheiro RF. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] [Internet]. Hematological Oncology. 2019 ; 37( 4): 523-526.[citado 2024 maio 21 ] Available from: https://doi.org/10.1002/hon.2608 -
Vancouver
Sousa JC, Ito MN, Costa MB, Farias IR, Borges DP, Oliveira RT, Fukutani KF, Thomé CH, Martinelli CMS, Myajima F, Vidal DO, Magalhães SMM, Pontes LL de F, Pinheiro RF. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] [Internet]. Hematological Oncology. 2019 ; 37( 4): 523-526.[citado 2024 maio 21 ] Available from: https://doi.org/10.1002/hon.2608 - Modulação da via de sinalização do TGFß e do VEGF pela oncoproteína PML-RARa
- Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma
- Síndrome de diferenciação concomitante à infecção por COVID-19 em paciente com leucemia promielocítica aguda
- Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
- Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta]
- Ischemic stroke in patients with philadelphia-negative classical myeloproliferative neoplasms: epidemiology and risk factors in a single center institution
- Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms
- Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients
- Deregulation of bone marrow eicosanoids in essential thrombocythemia and primary myelofibrosis patients
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
Informações sobre o DOI: 10.1002/hon.2608 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
